Carlo Lanza，医学博士，哲学博士
执行医疗主任

Carlo Lanza, MD, PhD, is executive medical officer for Labcorp Clinical Development Services, based in Lugano, Switzerland. Dr. Lanza performs medical monitoring and safety assessments on Phase I-IV clinical trials for Labcorp clients. 他负责领导早期和转化研究早期研发项目，针对靶向疗法、小分子、生物制剂和基因疗法。 Dr. Lanza also oversees development of late-stage development strategies and delivery and approval of registrational programs.他在临床研发方面拥有超过20年经验，并曾担任医师和医疗主任，专长于儿科和肿瘤学。 Before joining Labcorp, he served as medical director for medicines at Malaria Venture in Geneva, Switzerland. Dr. Lanza also has held leadership positions with Novartis Oncology, Pfizer Global Research and Development, and AstraZeneca U.K. He joined Labcorp in 2012.